| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Wichor M. Bramer | Q35703475 |
| Carla C Baan | Q52855873 | ||
| Martin J Hoogduijn | Q91695787 | ||
| Franka Luk | Q95944868 | ||
| P2093 | author name string | Samantha F H de Witte | |
| P2860 | cites work | Multilineage potential of adult human mesenchymal stem cells | Q27860737 |
| Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study | Q29617267 | ||
| Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells | Q29618766 | ||
| Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli | Q29618769 | ||
| Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production | Q29619807 | ||
| Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile | Q33532608 | ||
| Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study | Q33767123 | ||
| Alteration of naïve and memory B-cell subset in chronic graft-versus-host disease patients after treatment with mesenchymal stromal cells | Q34109382 | ||
| Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study | Q34132522 | ||
| Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials | Q34469147 | ||
| Mesenchymal stem cell as salvage treatment for refractory chronic GVHD | Q34562177 | ||
| Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis | Q34564111 | ||
| Safety and tolerability of human placenta-derived cells (PDA001) in treatment-resistant crohn's disease: a phase 1 study | Q34749491 | ||
| Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial. | Q35082549 | ||
| Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study | Q35757641 | ||
| Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjögren syndrome | Q36318183 | ||
| A placebo-controlled, randomized trial of mesenchymal stem cells in COPD. | Q36411255 | ||
| Mesenchymal stromal cells treatment attenuates dry eye in patients with chronic graft-versus-host disease | Q36460492 | ||
| Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients | Q36861401 | ||
| Mesenchymal Stem Cells in Solid Organ Transplantation (MiSOT) Fourth Meeting: lessons learned from first clinical trials. | Q37079961 | ||
| Systematic analysis of donor and isolation factor's impact on human islet yield and size distribution | Q37582562 | ||
| Bone marrow mesenchymal stromal cells to treat tissue damage in allogeneic stem cell transplant recipients: correlation of biological markers with clinical responses. | Q37710227 | ||
| Safety and efficacy of mesenchymal stromal cell therapy in autoimmune disorders | Q38035446 | ||
| The mesenchymal stromal cells dilemma--does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road? | Q38069258 | ||
| The life and fate of mesenchymal stem cells | Q38218112 | ||
| Efficacy and safety of mesenchymal stromal cell treatment from related donors for patients with refractory aplastic anemia | Q38450575 | ||
| Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial | Q38474282 | ||
| Mesenchymal stem cells are a rescue approach for recovery of deteriorating kidney function | Q38986069 | ||
| Phase II trial: undifferentiated versus differentiated autologous mesenchymal stem cells transplantation in Egyptian patients with HCV induced liver cirrhosis | Q38986075 | ||
| Multipotent Mesenchymal Stromal Cells for the Prophylaxis of Acute Graft-versus-Host Disease-A Phase II Study. | Q40235917 | ||
| Randomized trial of autologous bone marrow mesenchymal stem cells transplantation for hepatitis B virus cirrhosis: regulation of Treg/Th17 cells. | Q42211604 | ||
| Treatment of graft versus host disease with mesenchymal stromal cells: a phase I study on 40 adult and pediatric patients | Q42237533 | ||
| Mesenchymal stem cells versus mesenchymal stem cells combined with cord blood for engraftment failure after autologous hematopoietic stem cell transplantation: a pilot prospective, open-label, randomized trial | Q42627396 | ||
| Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning | Q43181730 | ||
| Alterations in the cellular immune compartment of patients treated with third-party mesenchymal stromal cells following allogeneic hematopoietic stem cell transplantation | Q43678493 | ||
| Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis | Q43831215 | ||
| Co-infusion of donor adipose tissue-derived mesenchymal and hematopoietic stem cells helps safe minimization of immunosuppression in renal transplantation - single center experience | Q43873016 | ||
| Unrelated allogeneic bone marrow-derived mesenchymal stem cells for steroid-refractory acute graft-versus-host disease: a phase I/II study. | Q44268056 | ||
| Cotransplantation of haploidentical hematopoietic and umbilical cord mesenchymal stem cells with a myeloablative regimen for refractory/relapsed hematologic malignancy. | Q44578369 | ||
| Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolate | Q44669692 | ||
| Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation | Q44746492 | ||
| Gastrointestinal acute graft-versus-host disease in children: histology for diagnosis, mesenchymal stromal cells for treatment, and biomarkers for prediction of response | Q45157046 | ||
| Allogeneic human mesenchymal stem cell therapy (remestemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patients | Q45308238 | ||
| Donor-derived mesenchymal stem cells combined with low-dose tacrolimus prevent acute rejection after renal transplantation: a clinical pilot study | Q45354237 | ||
| Mesenchymal stromal cells infusions improve refractory chronic graft versus host disease through an increase of CD5+ regulatory B cells producing interleukin 10. | Q45866879 | ||
| A modified haploidentical nonmyeloablative transplantation without T cell depletion for high-risk acute leukemia: successful engraftment and mild GVHD. | Q45933896 | ||
| Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease. | Q45962719 | ||
| Short-term evaluation of autologous transplantation of bone marrow-derived mesenchymal stem cells in patients with cirrhosis: Egyptian study | Q46177862 | ||
| A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy | Q47968884 | ||
| Long term effects of the implantation of Wharton's jelly-derived mesenchymal stem cells from the umbilical cord for newly-onset type 1 diabetes mellitus. | Q51348903 | ||
| Mesenchymal stromal cell therapy for steroid-refractory acute and chronic graft versus host disease: a phase 1 study | Q57254134 | ||
| P433 | issue | 5 | |
| P921 | main subject | immunotherapy | Q1427096 |
| systematic review | Q1504425 | ||
| mesenchymal stem cell | Q1922379 | ||
| P1104 | number of pages | 20 | |
| P304 | page(s) | 617-636 | |
| P577 | publication date | 2015-03-27 | |
| P1433 | published in | Expert Review of Clinical Immunology | Q15733763 |
| P1476 | title | Efficacy of immunotherapy with mesenchymal stem cells in man: a systematic review | |
| P478 | volume | 11 |
| Q90733799 | Cell membrane and bioactive factors derived from mesenchymal stromal cells: Cell-free based therapy for inflammatory bowel diseases |
| Q41046577 | Cryopreserved Mesenchymal Stromal Cells Are Susceptible to T-Cell Mediated Apoptosis Which Is Partly Rescued by IFNγ Licensing. |
| Q50224283 | Cryopreserved or Fresh Mesenchymal Stromal Cells: Only a Matter of Taste or Key to Unleash the Full Clinical Potential of MSC Therapy? |
| Q42211281 | Cytokine treatment optimises the immunotherapeutic effects of umbilical cord-derived MSC for treatment of inflammatory liver disease. |
| Q38569715 | Exploring cell-based tolerance strategies for hand and face transplantation |
| Q36939755 | Human Mesenchymal Stem Cells Genetically Engineered to Overexpress Brain-derived Neurotrophic Factor Improve Outcomes in Huntington's Disease Mouse Models. |
| Q38849206 | Identification and Characterization of Human Endometrial Mesenchymal Stem/Stromal Cells and Their Potential for Cellular Therapy |
| Q58590764 | Immunogenic potential of human bone marrow mesenchymal stromal cells is enhanced by hyperthermia |
| Q59132146 | Improving Immunotherapy Through Glycodesign |
| Q28069954 | Improving the outcome of kidney transplantation by ameliorating renal ischemia reperfusion injury: lost in translation? |
| Q42362354 | Membrane particles generated from mesenchymal stromal cells modulate immune responses by selective targeting of pro-inflammatory monocytes |
| Q52589273 | Mesenchymal stromal cells: a novel therapy for the treatment of chronic obstructive pulmonary disease? |
Search more.